Item Type | Name |
Concept
|
Autoimmune Diseases
|
Concept
|
Central Nervous System Diseases
|
Concept
|
Cerebellar Diseases
|
Concept
|
Charcot-Marie-Tooth Disease
|
Concept
|
Chronic Disease
|
Concept
|
Demyelinating Diseases
|
Concept
|
Disease Models, Animal
|
Concept
|
Immune Complex Diseases
|
Concept
|
Kidney Diseases
|
Concept
|
Muscular Diseases
|
Concept
|
Musculoskeletal Diseases
|
Concept
|
Nervous System Diseases
|
Concept
|
Neuromuscular Diseases
|
Concept
|
Peripheral Nervous System Diseases
|
Concept
|
Motor Neuron Disease
|
Concept
|
Infectious Disease Transmission, Patient-to-Professional
|
Concept
|
Disease Progression
|
Concept
|
Neurodegenerative Diseases
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Autoimmune Diseases of the Nervous System
|
Concept
|
Demyelinating Autoimmune Diseases, CNS
|
Concept
|
Asymptomatic Diseases
|
Academic Article
|
Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
|
Academic Article
|
Peripheral neuropathies in Sjogren syndrome: a new reappraisal.
|
Academic Article
|
Pathophysiology of inflammatory and autoimmune myopathies.
|
Academic Article
|
Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
|
Academic Article
|
Pathogenesis and therapies of immune-mediated myopathies.
|
Academic Article
|
Advances in the diagnosis, pathogenesis and treatment of CIDP.
|
Academic Article
|
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.
|
Academic Article
|
Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis.
|
Academic Article
|
Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome?
|
Academic Article
|
GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM.
|
Academic Article
|
Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations.
|
Academic Article
|
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record.
|
Academic Article
|
Immunotherapy in autoimmune neuromuscular disorders.
|
Academic Article
|
Basic principles of immunotherapy for neurologic diseases.
|
Academic Article
|
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
|
Academic Article
|
Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy.
|
Academic Article
|
A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin.
|
Academic Article
|
Intravenous immunoglobulin in autoimmune neuromuscular diseases.
|
Academic Article
|
The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
|
Academic Article
|
Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?
|
Academic Article
|
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy.
|
Academic Article
|
The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
|
Academic Article
|
Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.
|
Academic Article
|
Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy.
|
Academic Article
|
Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands.
|
Academic Article
|
Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.
|
Academic Article
|
Inflammatory, immune, and viral aspects of inclusion-body myositis.
|
Academic Article
|
B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
|
Academic Article
|
Variable pathogenic potentials of mutations located in the desmin alpha-helical domain.
|
Academic Article
|
Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.
|
Academic Article
|
Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
|
Academic Article
|
Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.
|
Academic Article
|
Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins.
|
Academic Article
|
Absence of upregulated genes associated with protein accumulations in desmin myopathy.
|
Academic Article
|
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
|
Academic Article
|
Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge.
|
Academic Article
|
Invited article: inhibition of B cell functions: implications for neurology.
|
Academic Article
|
Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".
|
Academic Article
|
IVIg in other autoimmune neurological disorders: current status and future prospects.
|
Academic Article
|
B cells as therapeutic targets in autoimmune neurological disorders.
|
Academic Article
|
In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.
|
Academic Article
|
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
|
Academic Article
|
Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.
|
Academic Article
|
Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations.
|
Academic Article
|
Inflammatory muscle diseases.
|
Academic Article
|
Inflammatory Muscle Diseases.
|
Academic Article
|
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
|
Academic Article
|
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
|
Academic Article
|
Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.
|
Academic Article
|
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease.
|
Academic Article
|
Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder.
|
Academic Article
|
Case 22-2019: A 65-Year-Old Woman with Myopathy.
|
Academic Article
|
Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
|
Academic Article
|
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
|
Academic Article
|
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece.
|
Academic Article
|
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases.
|
Academic Article
|
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
|
Academic Article
|
Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies.
|
Academic Article
|
Progressive multifocal fibrosing neuropathy: description of a novel disease.
|
Academic Article
|
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.
|
Academic Article
|
Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies.
|
Academic Article
|
First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center.
|
Academic Article
|
Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.
|
Academic Article
|
Autoimmune inflammatory myopathies.
|
Academic Article
|
The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology.
|